Glutamate antagonists are neurotoxins for the developing brain-Reference-Cited by-同舟云学术

Glutamate antagonists are neurotoxins for the developing brain

Published:2007-09 Issue:3-4 Volume:11 Page:203-218
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:neurotox res

Author:

Kaindl Angela M.,Ikonomidou Chrysanthy

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/BF03033568.pdf

Reference147 articles.

1. Aamodt SM and M Constantine-Paton (1999) The role of neural activity in synaptic development and its implications for adult brain function.Adv. Neurol. 79, 133–144.

2. Agmon A and DK O’Dowd (1992) NMD A receptor-mediated currents are prominent in the thalamocortical synaptic response before maturation of inhibition.J. Neurophysiol. 68, 345–349.

3. Anwyl R (1999) Metabotropic glutamate receptors: electro- physiological properties and role in plasticity.Brain Res. Rev. 29, 83–120.

4. Bambrick LL, PJ Yarowsky and BK Krueger (1995) Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.Proc. Natl. Acad. Sci. USA 92, 9692–9696.

5. Bardoul M, MJ Drian and N König (1997) AMPA/kainate receptors modulate the survivalin vitro of embryonic brain-stem cells.Int. J. Dev. Neurosci. 15, 695–701.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular events in brain bilirubin toxicity revisited;Pediatric Research;2024-02-20

2. Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-06-26

3. Unilateral Transient Enhanced SEP during Integrated Multiparameter Neurophysiological Monitoring in a Newborn with Symptomatic Seizure;Pediatric Reports;2022-05-27

4. GABA and glutamate in the preterm neonatal brain: In-vivo measurement by magnetic resonance spectroscopy;NeuroImage;2021-09

5. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?;Frontiers in Pharmacology;2021-02-04